83
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors

, &
Pages 221-229 | Published online: 26 Mar 2010

References

  • MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res198646638763922946403
  • SledgeGWJrMillerKDExploiting the hallmarks of cancer: the future conquest of breast cancerEur J Cancer2003391668167512888360
  • WuJAkaikeTMaedaHModulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavengerCancer Res1998581591659426072
  • LamprechtAUbrichNYamamotoHBiodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel diseaseJ Pharmacol Exp Ther200129977578111602694
  • YouSLiWAdministration of nanodrugs in proper menstrual stage for maximal drug retention in breast cancerMed Hypotheses20087114114718299174
  • YouSLiWKobayashiMCreation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumorIn Vitro Cell Dev Biol Anim20044018719515161341
  • WoodPABoveKYouSCancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesisMol Cancer Ther200541065107516020664
  • ChuACTsangSYLoEHLow density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cellsLife Sci20017059160111811903
  • LoEHOoiVEFungKPCircumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoproteinLife Sci20027267768712467908
  • CharroisGJAllenTMRate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activityBiochim Biophys Acta2003160910210812507764
  • FordCEEkstromEJAnderssonTWnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cellsProc Natl Acad Sci U S A20091063919392419237581
  • BergmanMDSchachterBSKarelusKUp-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiolEndocrinology1992130192319301547720
  • MichaelSDPlasma prolactin and progesterone during the estrous cycle in the mouseProc Soc Exp Biol Med19761532542571033549
  • RiveraELiposomal anthracyclines in metastatic breast cancer: clinical updateOncologist20038Suppl 23913679590
  • WahlAFDonaldsonKLMixanBJSelective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicinInt J Cancer20019359060011477565
  • SinhaBKKatkiAGBatistGDifferential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of actionBiochemistry198726377637812820475
  • BachurNRYuFJohnsonRHelicase inhibition by anthracycline anticancer agentsMol Pharmacol1992419939981614415
  • CrespiMDIvanierSEGenoveseJMitoxantrone affects topoisomerase activities in human breast cancer cellsBiochem Biophys Res Commun19861365215283010982
  • HortobagyiGNBuzdarAUMarcusCEImmediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor InstituteNCI Monogr198611051093534581
  • MuggiaFMClinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancersDrugs199754Suppl 422299361958
  • HarmeyJHBucanaCDLuWLipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasionInt J Cancer200210141542212216068
  • PidgeonGPHarmeyJHKayEThe role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic diseaseBr J Cancer1999811311131710604727
  • DuPreSARedelmanDHunterKWJrThe mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour fociInt J Exp Pathol20078835136017877537
  • TohyamaMSayamaKKomatsuzawaHCXCL16 is a novel mediator of the innate immunity of epidermal keratinocytesInt Immunol2007191095110217855433
  • JablonskaERelease of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patientsCancer Lett1997119798518372525
  • HoriuchiTWellerPFExpression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5Am J Respir Cell Mol Biol19971770779224211